Literature DB >> 22624490

Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria.

Hazel J Clothier1, Nigel W Crawford, Ann Kempe, Jim P Buttery.   

Abstract

State-based adverse events following immunisation (AEFI) reporting systems in Australia demonstrate marked regional differences in surveillance methodologies and reporting rates. To improve AEFI services in Victoria, Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) was established in 2007. SAEFVIC comprises a central reporting enhanced passive surveillance system integrated with clinical services. AEFI may be reported by phone, fax or on-line. Immunisation nurse specialists follow up all reports, coupled with physician review as required. Supervised re-vaccination in a hospital environment, when appropriate, helps ensure clinical support for vaccinees, families and health-care providers. The Brighton Collaboration, the Australian Immunisation Handbook and in-house case definitions are used to categorise AEFI reports. In the first 3 years (2007-2010) of operation 3,265 reports were received, describing 4,293 AEFI. The number of reports received increased annually over the 3-year period. Seventy-six per cent of AEFI met one of 52 established case definitions and the remainder were recorded verbatim: 22% of reported AEFI were considered severe. Of 1,086 persons reporting an AEFI in 2009, 356 (36%) attended for a clinical consultation and 325 (83%) were revaccinated, of which 114 were day stay or overnight patients. Enhanced passive AEFI surveillance using integrated clinical services has been shown to improve adverse event reporting with reporting rates in Victoria increasing from 2.6 per 100,000 in 2003 to 13.5 per 100,000 per annum in 2009. This report describes the SAEFVIC service model and summarises outcomes and lessons learnt in the first 3 years of operation.

Entities:  

Mesh:

Year:  2011        PMID: 22624490

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  21 in total

1.  Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia.

Authors:  C-M Baxter; H J Clothier; K P Perrett
Journal:  Hum Vaccin Immunother       Date:  2018-05-10       Impact factor: 3.452

2.  Consumer reporting of adverse events following immunization.

Authors:  Hazel J Clothier; Gowri Selvaraj; Mee Lee Easton; Georgina Lewis; Nigel W Crawford; Jim P Buttery
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

4.  Canadian paediatricians' approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network.

Authors:  Karina A Top; Joseline Zafack; Gaston De Serres; Scott A Halperin
Journal:  Paediatr Child Health       Date:  2014-06       Impact factor: 2.253

5.  Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia.

Authors:  E S Littlejohn; H J Clothier; K P Perrett; M Danchin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.

Authors:  Hazel J Clothier; Laine Hosking; Nigel W Crawford; Melissa Russell; Mee Lee Easton; Julie-Ann Quinn; Jim P Buttery
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

7.  Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12-17-year olds in Victoria, Australia.

Authors:  Daryl R Cheng; Hazel J Clothier; Hannah J Morgan; Emma Roney; Priya Shenton; Nicholas Cox; Bryn O Jones; Silja Schrader; Nigel W Crawford; Jim P Buttery
Journal:  BMJ Paediatr Open       Date:  2022-06

8.  Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.

Authors:  Cristiano Alicino; Caterina Merlano; Simona Zappettini; Sergio Schiaffino; Giovanni Della Luna; Cristina Accardo; Roberto Gasparini; Paolo Durando; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.

Authors:  Sally F Gordon; Elise Virah Sawmy; Eleanor Duckworth; Michelle Wolthuizen; Hazel J Clothier; Malinda Chea; Naveen Tenneti; Ngaree Blow; Jim P Buttery; Joseph de Luca; Tony M Korman; Sara Barnes; Charlotte Slade; Callum Maggs; Michelle L Giles; Benjamin W Teh; Craig Aboltins; Katherine M Langan; Annaliese Van Diemen; Nigel W Crawford
Journal:  Hum Vaccin Immunother       Date:  2022-04-26       Impact factor: 4.526

10.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.